Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09VBE
|
||||
Former ID |
DNCL001873
|
||||
Drug Name |
Elinogrel
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Myocardial infarction [ICD9: 410; ICD10:I21, I22] | Phase 1 | [522795] | ||
Company |
Novartis Pharmaceuticals; Portola Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H15ClFN5O5S2
|
||||
Canonical SMILES |
CNC1=C(C=C2C(=C1)NC(=O)N(C2=O)C3=CC=C(C=C3)NC(=O)NS(=O)<br />(=O)C4=CC=C(S4)Cl)F
|
||||
InChI |
1S/C20H15ClFN5O5S2/c1-23-15-9-14-12(8-13(15)22)18(28)27(20(30)25-14)11-4-2-10(3-5-11)24-19(29)26-34(31,32)17-7-6-16(21)33-17/h2-9,23H,1H3,(H,25,30)(H2,24,26,29)
|
||||
InChIKey |
LGSDFTPAICUONK-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 936500-94-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | P2Y purinoceptor 12 | Target Info | Antagonist | [530744] | |
KEGG Pathway | Platelet activation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.